HOME JOURNALS CONTACT

Asian Journal of Clinical Nutrition

Year: 2015 | Volume: 7 | Issue: 2 | Page No.: 22-32
DOI: 10.3923/ajcn.2015.22.32
Nutraceutical Potential of Soybean: Review
Shashank A. Tidke, D. Ramakrishna, S. Kiran, G. Kosturkova and G.A. Ravishankar

Abstract: Soybean has received the status as one of the most important edible plants known for its seeds as a source of protein, oil and nutraceuticals. The content of the isoflavones and folic acid has made it a versatile crop for health food applications. The utility of soybean crop for food applications is described. The soybean proteins are gaining importance as a vegetable source for protein based products, with abundance quantity of essential amino acids. Its content of quality fats and PUFA are also important from nutraceutical point of view. The fermented soybean meal is also a good source of nutritionally rich tofu. In addition the biological properties of isoflavones and folic acid add value to the formulations which has been described here. Patents filed for innovations in products and processes have gained popularity and holds promise for the future of soybean industry.

Fulltext PDF Fulltext HTML

How to cite this article
Shashank A. Tidke, D. Ramakrishna, S. Kiran, G. Kosturkova and G.A. Ravishankar, 2015. Nutraceutical Potential of Soybean: Review. Asian Journal of Clinical Nutrition, 7: 22-32.

Keywords: PUFA, Soybean, glycine max, nutraceutical, health foods, isoflavones, folic acid and essential amino acids

INTRODUCTION

Origin and history: Soybean (Glycine max Leguminosae) is an important grain legume that is not only a valuable oil crop but also used as feed for livestock and aquaculture. The origin and history of soybean plant is not known clearly, however, ancient Chinese literature points out that as early as in 2853BC, the Emperor Sheng-Nung of China named soybean as one of the five scared grain (Hymowitz, 1970). The crop was first cultivated during the shang dynasty in the eastern half of the north china, which is believed to be the center of origin for soybean. Soybean has been cultivated in China for more than 4,000 years. Soybean is a commercial crop and grown in over 35 countries as the major oil seed (Smith and Huyser, 1987). Globally 38% of total soybean crop is grown in US; followed by Brazil (25%) Argentina (19%), China (7%), India (3%), Canada (2%) and Paraguay (2%) (Singh et al., 2008). The native of soybean is China, the major producers in the world of soybean products are the United States, Brazil, Argentina and India have been extensively used as important source of dietary protein and oil throughout the world.

Plant characteristics: The genus Glycine is divided into two subgenera: Glycine and Soja. The former consists of Glycine canescens and Glycine tomentella Hayata perennial wild species. Three annual species from Asia Glycine max, Glycine soja and Glycine gracilis. Glycine max is cultivated worldwide (Hymowitz and Newell, 1981), whereas Glycine soja is cultivated in China, Japan, Korea, Russia and Taiwan and Glycine gracilis is cultivated only in china (Hymowitz and Singh, 1987). Soybean is an annual plant, grows prostrate with pods, stems and leaves covered by fine brown or grey hairs. Leaves are trifoliate having 3-4 leaflets per leaf and fall before the seed mature (Lersten and Carlson, 1987). Soybean fruit is simple or curve shape of the waxing pod, 3-7 cm length, including 1 or 2 seeds. Unripe seeds are green in color and mature have from light yellow by green to brown color. Modern cultivar of soybean seeds have spherical shape and yellow and green color is the most desirable (Sikorski, 2007). Flowers are papilionaceous type and purple, pink and white in color. Anthers mature in the bud and shed their pollen directly onto the stigma of the same flower and soybean flower is high degree of self pollination (Lersten and Carlson, 1987).

Soybean as food ingredient: Soybean is used as raw material for oil milling and soy residue used as feedstuff for domestic animals. Soybean contains a high nutritional value due to the high concentration of oil (18-25%) and protein (38-50%) and is a popular food all over the world (Muller et al., 1998). Production and consumption of soy product increased in western countries. In Asian countries soybean is used as fermented and non fermented food stuff such as soy sauce, miso, natto, yogurts, kinako, protein crisp, desserts, baby food and soy milk which is further processed into tofu, aburage and yuba (Hammond and Jez, 2011). Soybean base product are used as a primary protein source for several disorders such as lactose intolerance and severe gastroenteritis in infants (Businco et al., 1992). Mature seeds of soybean contains, approximately 35% protein, 31% carbohydrate, 17% fats, 5% mineral and 12% moisture (Messina and Lane, 2007). Soybean protein contain acceptable amount of essential amino acid i.e. histidine, isoleucine, leucine, lysine, phenylalanine, tyrosine, threonine, tryptophan and valine which is recommended for daily intake as a balanced diet (Erdman and Fordyce, 1989). The detailed composition of the nutrients is given in Table 1. Soybean has been reported to impart several health benefits such as lowering of plasma cholesterol (Anthony et al., 1996), prevention of cancer (Kennedy, 1998), improvement in bone mineral density (Kreijkamp-Kaspers et al., 2004) and provide protection against bowel and kidney disease (Friedman and Brandon, 2001). These health benefits are caused by the presence of isoflavone, saponins , protein and peptide in soybean (Friedman and Brandon, 2001; Michelfelder, 2009; Xiao, 2008).

Proteins: Liu (1997) has reported that Soybean contains 35-40% protein on a dry-weight basis, it include globulins, 11S glycinin and 7S β-conglycinin (Table 1). These proteins contain all amino acids essential to human nutrition, which makes soy products almost equivalent to animal sources in protein quality but with less saturated fat and no cholesterol. Soybean also contains the biologically active protein components hemagglutinin, trypsin inhibitors, α-amylase and lipoxygenases (Liu, 1997). As per the FDA’s ‘Protein Digestibility Corrected Amino Acid’source method, soybean is not only high quality protein, but it is now thought to play preventive and therapeutic roles for several diseases (Grieshop et al., 2003).

Oil: Soybean contains roughly ~19% oil, of which the triglycerides are the major component. Soy oil is characterized by relatively large amounts of the polyunsaturated fatty acids (PUFA), i.e., ~51% linoleic acid and ~8% α-linolenic acid, stearic acid ~4, palmitic acid ~10, oleic acid ~23 of total fatty acids (Messina, 1997) (Table 2). Soybean oil contains, essential fatty acids-linoleic acid and α-linolenic acid belonging to the ω-6 and ω-3 family, which plays an important role in the regulation of a number of metabolic pathways and exerts important nutritional and physiological functions.

Table 1: Concentration of amino acids in soybean (Dry weight basis)
Source: USDA nutrient database

Table 2: Concentration of oils, vitamins and nutraceuticals in soybean (Dry weight basis)
Source: USDA nutrient database

Oil also contains 1-3% phospholipids, ~35% phosphatidyl choline, ~25% phosphatidyl ethanolamine, ~15% phosphatidyl inositol, ~5-10% phosphatidic acid.

Carbohydrates: Soybean contains ~35% carbohydrates, polysaccharides, oligosaccharides such as, stachyose (4%) and raffinose (1.1%) (Table 2). Stachyose is a tetraose with a galactose galactose-glucose-fructose structure, while raffinose is a triose with a structure of galactose-glucose-fructose (Grieshop et al., 2003).

Table 3: Soybean products worldwide

Polysaccharides are composed mainly of insoluble dietary fiber. Soybean curd refuse (Okara) contains soluble polysaccharides with galacturonic acid. In addition to use as a dietary fiber supplement, soluble polysaccharides have been used to modify the physical properties of various foods (Espinosa-Martos and Ruperez, 2006).

Vitamins and minerals: Soybean is a better source of vitamins B compared to cereals, although it lacks B12 and vitamin C (Liu, 1997) (Table 2). Soybean oil also contains tocopherols which are tremendous natural antioxidants. Soybean also contains ~5% minerals. It is relatively rich in K, P, Ca, Mg and Fe. Soy ferritin can extra reasonable quantities of iron (Sugano, 2006).

SOYBEAN PRODUCT

Oriental soy foods, both fermented and nonfermented products are part of the daily diet in many areas of the world. Products such as soy sauce, tofu, tempeh and others are becoming more popular in the United States and Europe. Soy sauce is made either by hydrolysis or by fermentation. Some commercial sauces have both fermented and chemical sauces. Traditional soy sauces are made by mixing soybeans and grain with mold cultures such as Aspergillus oryzae and other related microorganisms and yeasts (Table 3). Soymilk originated in China. Soy milk is a complete protein; it can replace animal protein and other sources of dietary fiber, vitamins and minerals (Sacks et al., 2006). Soy products contain sucrose as the basic disaccharide, which breaks down into glucose and fructose. Since soy does not contain galactose a product of lactose breakdown, soy-based infant formulas can safely replace breast milk in children with galactosemia (Gandhi, 2008) (Table 2). Natto has a distinguishing smell, somewhat similar to a strong cheese. Stirring natto produces lots of sticky strings (Hosking, 1996). Natto is 55% water, 18% protein, 11% fats, 5% fiber and 5% sugars. It is traditional Japanese breakfast food made from fermented soybean with Bacillus subtilis as a rich source of protein (McCloud, 1992). Many companies are involved worldwide for soybean product (Table 4 and 5).

SOYBEAN AND HEALTH BENEFIT

Traditionally soybean based-foods of have been consumed for centuries in most of the Asian countries and recently, this food has had a great popularity in the west hemisphere (Messina, 2008). Transgenic soybean is included in agriculture technology to increase productivity primarily by reducing inputs and thus production cost (Persley et al., 1999).

Table 4: Companies involved in soybean products
Source: Wikipedia

Table 5: Soybean production worldwide
Source: USDA database

Soybean is gaining importance as a nutritionally important crop and also becoming popular for nutraceutical properties as it contains essential amino acid and secondary metabolites such as isoflavone, saponins, phytic acids, phytosterols, trypsin inhibitors and peptides (Isanga and Zhang, 2008). Soy, isoflavone daidzein and genistein, their precursors formononetin, biochanin A, their glycosides, glycosides malonates and acetyl glycosides were determined in red clover (Trifolium pratense) extracts using chromatographic and spectrometric methods (Sabudak and Guler, 2009) that are natural phytoestrogens able to inhibit LDL oxidation, thus decreasing the risk of atherosclerosis (Wiseman, 1999). Ito et al. (2006) isolated two new isoflavonoids from leaves of Millettia taiwaniana (Leguminosae), millewanin-F and furowanin-A, together with previously known five isoflavonoids. Wiseman et al. (2000) reported a decrease in susceptibility of LDL particles to oxidation with soy protein consumption. Isanga and Zhang (2008) reported that the phytochemicals contained in soybean as functional ingredients influences the reduction of cholesterol and prevention of cardiovascular diseases, diabetic symptoms, bone lose straight and cancer. Messina and Lane (2007) suggested that soybean-based food can help to reduce the level of cholesterol, soybean will help to this change since provide quality protein, in addition is low in saturated fat and is devoid of cholesterol. Tavva et al. (2007) reported that transgenic soybean with content of α-tocoferol by expressing the gene γ-tocoferol methyltransferase of Perilla frutescens which is used in prevention of oxidative damage of lipids during seed storage and germination. Eating soybeans, which are good sources of calcium and protein and easy way to help build strong bones and even reduce the risk of osteoporosis. Research shows that it is the isoflavones, genistein and daidzein in soybeans, that prevent bone loss or the breakdown of bones. Also, the protein in soybeans helps to conserve calcium in our bodies. The folic acid present in soybean has synergistic effects in prevention of bone loss. Isoflavones include a class of organic compounds, regularly naturally occurring, related to the isoflavonoids (Kaufman et al., 1997). Besides isoflavones, the other subclasses of flavonoids include flavonols, aurones, flavones, flavanols, chalcones, red and blue anthocyanin pigments. isoflavones is the phenyl ring B is connected at position 3 of 1, 4-benzopyrone ring. The soybean is most rich source of isoflavones (up to 3 mg g–1 dry weight) in the nature (Kudou et al., 1991). Chen et al. (2003) and Setchell et al. (2005) reported that after the soybean is consumed, the glycosidic forms of the isoflavones undergo hydrolysis due to the action of the brush border and bacterial β-glucosidases to remove the sugar moiety, the aglycone form is then either absorbed or undergoes further metabolism by intestinal bacteria in the large bowel . Devi et al. (2009) studied the functional attributes of soybean seeds and products, with reference to isoflavone content and antioxidant activity. Isoflavone prevent the different kinds of diseases like bone health, cancer, cardiovascular, menopause, diabetes and obesity (Dixit et al., 2011; Kushwaha et al., 2014). Bondesson and Gustafsson (2010) studied the epidemiological and clinical studies of isoflavone they have concluded that most epidemiological investigations have found that soy intake is associated with a modest reduction in breast cancer risk. Byun et al. (2010) evaluated the effects of consuming yellow soybeans, black soybeans (Glycine max) or sword beans (Canavalia gladiate) on lipid and oxidative stress levels in an ovaryectomized rat model. They have suggested that consumption of various types of beans may inhibit oxidative stress in postmenopausal women by increasing antioxidant activity and improving lipid profiles. Notably, intake of black soybean resulted in the greatest improvement in risk factors associated with cardiovascular disease. Sotoca et al. (2010) studied the quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen- genistein they have concluded that the effects of genistein on proteomics and transcriptomics end points in the T47D-ERβ cell model are comparable with those reported previously for estradiol with the ultimate estrogenic effect being dependent on the relative affinity for both receptors and on the receptor phenotype (ERα/ERβ ratio) in the cells or tissue of interest. Li et al. (2009) reported that genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms they have shown that genistein is working, at least in part, through epigenetic mechanisms of telomerase inhibition in breast benign and cancer cells and may facilitate approaches to breast cancer prevention and treatment using an epigenetic modulator combined with genistein. Soy extract is more potent than genistein in the inhibition of tumor growth (Kim et al., 2008). Nagarajan (2010) suggested that soy isoflavone might be restrain the endothelial cell activation effect which is associated to chronicle disease such as atherosclerosis by blocking the activation of inflammatory cells and the adhesion to the vascular endothelium. Furthermore the atherosclerotic protection of soy isoflavones is arbitrated through the regulation of monocyte activation.

Folate plays a vital role in the one-carbon metabolism for physiological nucleic acid synthesis and regulation of gene expression, cell division, neurotransmitter synthesis and amino acid metabolism (Djukic, 2007). Blencowe et al. (2010) studied folic acid to reduce neonatal mortality from neural tube disorders. Their study provides a quantitative estimate of the effect folic acid on the fall in risk of neonatal mortality by folic acid fortification and supplementation. Barua et al. (2014) has investigated the effect of folic acid supplementation in pregnancy and implications in health and disease. Folate can help to reduce risk of heart disease. Number of other health outcomes is highly controversial throughout the pregnancy by the effect of folate (Fekete et al., 2010). Soybean is a source of folic acid with about 2500 μg kg–1 on dry matter basis. There is scope for studying the folic acid levels in the processed grain and products there from, with bioaccessability of the vitamin. The processing conditions have adverse effects on folic acid levels. Folic acid has been implicated in many other health disorders like anemia, mal absorption of nutrients, brain development in infants, in treating Alzheimer’s disease, age related hearing loss etc. Therefore the diets rich in Soybean a good source of this vitamin could be of value to nutrition.

Table 6: Some recent representative patents on soybean

PATENTS ON SOYBEAN

Due to tremendous commercial importance of the soybean products, there is increasing rush to patent inventions of Soybean to compete in the world market (Table 6). The patents on soybean crop deal with its improvement both for productivity and also quality traits. Also the patents deal with the process of making several improved products which are of value in food and also in health foods sector. Thus the patents on soybean are ever increasing. Here only some representative ones are given to emphasize the importance of soybean patents from mentioned perspectives.

CONCLUSION

Soybean is becoming an important crop for its nutritional value and also health food applications. Though traditionally a crop of Asian region has been now cultivated extensively worldwide and the food technological developments have added a number of newer applications. The research on the elucidation of bioactive properties has been in full swing which adds greater credibility to the claims made for health applications. In view of its utility for isoflavones as the major bioactive molecules it is gaining importance in designer foods. The protein and the fermented products add value as nutritionally important recipes for people of all ages. As a source of edible oil this crop is already a big commercial success. The presence of folic acid is an additional attraction, since the deficiency of this nutrient is a serious concern globally. Though raw soybean contain about 2500 μg kg–1 on dry matter basis, cooked tempe will have additional benefit of B12 vitamin and isoflavone and the folic acid retained, with bioaccessability of over 80%. Thus soybean has a great potential as a source of important nutrients and nutraceuticals of implication to human health. Therefore the innovations that is taking place has in the development of processes and products of soybean will provide further boost to the aspect of utilization of soybean beyond the usage as oil seed crop.

ACKNOWLEDGMENTS

Authors are thankful to Vice Chairman Dr. Premachandra Sagar for his keen support and encouragement. Further the financial assistance by Dayananda Sagar Institutions is gratefully acknowledged. RAG wishes to thank Department of Science and Technology, Government of India for financial support through competitive grant.

REFERENCES

  • Anthony, M.S., T.B. Clarkson, C.L. Hughes, Jr., T.M. Morgan and G.L. Burke, 1996. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr., 126: 43-50.
    PubMed    Direct Link    


  • Blencowe, H., S. Cousens, B. Modell and J. Lawn, 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int. J. Epidemiol., 39: 110-121.
    CrossRef    Direct Link    


  • Businco, L., G. Bruno, P.G. Giampietro and A. Cantani, 1992. Allergenicity and nutritional adequacy of soy protein formulas. J. Pediatr., 121: S21-S28.
    CrossRef    Direct Link    


  • Byun, J.S., Y.S. Han and S.S. Lee, 2010. The effects of yellow soybean, black soybean and sword bean on lipid levels and oxidative stress in ovariectomized rats. Int. J. Vitamin Nutr. Res., 80: 97-106.
    CrossRef    Direct Link    


  • Chen, W.F., M.H. Huang, C.H. Tzang, M. Yang and M.S. Wong, 2003. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1638: 187-196.
    CrossRef    Direct Link    


  • Devi, M.K.A., M. Gondi, G. Sakthivelu, P. Giridhar, T. Rajasekaran and G.A. Ravishankar, 2009. Functional attributes of soybean seeds and products, with reference to isoflavone content and antioxidant activity. Food Chem., 114: 771-776.
    CrossRef    Direct Link    


  • Dixit, A.K., J.I.X. Antony, N.K. Sharma and R.K. Tiwari, 2011. Soybean Constituents and their Functional Benefits. In: Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry, Tiwari, V.K. and B.B. Mishra (Eds.). Research Signpost, Trivandrum, India, ISBN-13: 9788130804484


  • Djukic, A., 2007. Folate-responsive neurologic diseases. Pediatr. Neurol., 37: 387-397.
    CrossRef    Direct Link    


  • Erdman, J.W. Jr. and E.J. Fordyce, 1989. Soy products and the human diet. Am. J. Clin. Nutr., 49: 725-737.
    Direct Link    


  • Espinosa-Martos, I. and P. Ruperez, 2006. Soybean oligosaccharides: Potential as new ingredients in functional food. Nutr. Hosp., 21: 92-96.
    Direct Link    


  • Fekete, K., C. Berti, I. Cetin, M. Hermoso, B.V. Koletzko and T. Decsi, 2010. Perinatal folate supply: Relevance in health outcome parameters. Maternal Child Nutr., 6: 23-38.
    Direct Link    


  • Friedman, M. and D.L. Brandon, 2001. Nutritional and health benefits of soy proteins. J. Agric. Food Chem., 49: 1069-1086.
    CrossRef    PubMed    Direct Link    


  • Gandhi, A.P., 2008. Development of HACCP procedure for the production of full fat soy flour. Int. Food Res. J., 15: 141-154.
    Direct Link    


  • Grieshop, C.M., C.T. Kadzere, G.M. Clapper, E.A. Flickinger, L.L. Bauer, R.L. Frazier and G.C. Fahey Jr., 2003. Chemical and nutritional characteristics of united states soybeans and soybean meals. Agric. Food Chem., 51: 7684-7691.
    CrossRef    Direct Link    


  • Hammond, B.G. and J.M. Jez, 2011. Impact of food processing on the safety assessment for proteins introduced into biotechnology-derived soybean and corn crops. Food Chem. Toxicol., 49: 711-721.
    CrossRef    Direct Link    


  • Hosking, R., 1996. A Dictionary of Japanese Food: Ingredients and Culture. Tuttle Publishing, Boston, MA., Pages: 239


  • Hymowitz, T., 1970. On the domestication of the soybean. Econ. Bot., 23: 408-421.
    CrossRef    Direct Link    


  • Hymowitz, T. and C.A. Newell, 1981. Taxonomy of the genus Glycine, domestication and uses of soybeans. Econ. Bot., 35: 272-288.
    CrossRef    Direct Link    


  • Hymowitz, T. and R.J. Singh, 1987. Taxonomy and Speciation. In: Soybeans: Improvement, Production and Uses, Wilcox, J.R. (Ed.). 2nd Edn., CSSA and SSSA, Madison, ASA, WI, pp: 134-179


  • Isanga, J. and G.N. Zhang, 2008. Soybean bioactive components and their implications to health-a review. Food Rev. Int., 24: 252-276.
    CrossRef    Direct Link    


  • Kaufman, P.B., J.A. Duke, H. Brielmann, J. Boik and J.E. Hoyt, 1997. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: Implications for human nutrition and health. J. Alter. Complementary Med., 3: 7-12.
    CrossRef    PubMed    Direct Link    


  • Kennedy, A.R., 1998. The bowman-birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68: 1406S-1412S.
    Direct Link    


  • Kim, H.A., K.S. Jeong and Y.K. Kim, 2008. Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res., 28: 2837-2841.
    Direct Link    


  • Kreijkamp-Kaspers, S., L. Kok, D.E. Grobbee, E.H. de Haan, A. Aleman, J.W. Lampe and Y.T. van der Schouw, 2004. Effect of soy protein containing isoflavones on cognitive function, bone mineral density and plasma lipids in postmenopausal women: A randomized controlled trial. J. Am. Med. Assoc., 292: 65-74.
    CrossRef    PubMed    Direct Link    


  • Kudou, S., Y. Fleury, D. Welti, D. Magnolato, T. Uchida, K. Kitamura and K. Okubo, 1991. Malonyl isoflavone glycosides in soybean seeds (Glycine max Merrill). Agric. Biol. Chem., 55: 2227-2233.
    Direct Link    


  • Kushwaha, K., C.A. O'Bryan, D. Babu, P.G. Crandall, O. Chen and S.O. Lee, 2014. Human health effects of isoflavones from soybeans. Agric. Food Anal. Bacteriol., 4: 122-142.


  • Lersten, N.R. and J.B. Carlson, 1987. Vegetative Morphology. In: Soybeans: Improvement, Production and Uses, Wilcox, J.R. (Ed.). 2nd Edn., American Society of Agronomy, Madison, WI., pp: 49-94


  • Liu, K.S., 1997. Chemistry and Nurtitional Value of Soybean Components. In: Soybeans: Chemistry, Technology and Utilization, Liu, K.S. (Ed.). Chapman and Hall, New York, USA., pp: 25-113


  • Li, Y., L. Liu, L.G. Andrews and T.O. Tollefsbol, 2009. Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms. Int. J. Cancer, 125: 286-296.
    CrossRef    Direct Link    


  • Bondesson, M. and J.A. Gustafsson, 2010. Does consuming isoflavones reduce or increase breast cancer risk? Genome Med., Vol. 2.
    CrossRef    


  • McCloud, T., 1992. Natto: A Breakfast Dish that's an Acquired Taste. Daily Press, Virginia, USA


  • Messina, M.J., 1997. Soybean Foods: Their Role in Disease Prevention and Treatment. In: Soybeans: Chemistry, Technology and Utilization, Liu, K.S. (Ed.). Chapman and Hall, New York, USA., pp: 442-466


  • Messina, M., 2008. Investigating the optimal soy protein and isoflavone intakes for women: A perspective. Women's Health, 4: 337-356.
    CrossRef    PubMed    Direct Link    


  • Messina, M. and B. Lane, 2007. Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand? Future Lipidol., 2: 55-74.
    CrossRef    Direct Link    


  • Michelfelder, A.J., 2009. Soy: A complete source of protein. Am. Fam. Physician, 79: 43-47.
    PubMed    Direct Link    


  • Muller, U., W. Weber, A. Hoffmann, S. Franke, R. Lange and S. Vieths, 1998. Commercial soybean lecithins: A source of hidden allergens? Zeitschrift Lebensmitteluntersuchung Und-Forschung A, 207: 341-351.
    CrossRef    Direct Link    


  • Ito, C., T. Murata, M. Itoigawa, K. Nakao, M. Kumagai, N. Kaneda and H. Furukawa, 2006. Induction of apoptosis by isoflavonoids from the leaves of Millettia taiwaniana in human leukemia HL-60 cells. Planta Medica, 72: 424-429.
    CrossRef    Direct Link    


  • Nagarajan, S., 2010. Mechanisms of anti-atherosclerotic functions of soy-based diets. J. Nutr. Biochem., 21: 255-260.
    CrossRef    PubMed    Direct Link    


  • Persley, G.J., J.N. Siedow, M. Gasson and C.O. Qualset, 1999. Applications of biotechnology to crops: Benefits and risks. Council for Agricultural Science and Technology, Issue Paper 12, December 1999, pp: 1-8.


  • Setchell, K.D., C. Clerici, E.D. Lephart, S.J. Cole and C. Heenan et al., 2005. S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr., 81: 1072-1079.
    PubMed    Direct Link    


  • Sabudak, T. and N. Guler, 2009. Trifolium L.-a review on its phytochemical and pharmacological profile. Phytother. Res., 23: 439-446.
    CrossRef    PubMed    Direct Link    


  • Sikorski, Z.E., 2007. Chemia Zywnosci. 5th Edn., Wnt, Sweden, ISBN-13: 978-8320432732, Pages: 244


  • Smith, K.L. and W. Huyser, 1987. World Distribution and Significance of Soybean. In: Soybeans: Improvement, Production and uses, Wilcox, J.R. (Ed.). 2nd Edn., American Society of Agronomy, Madison, WI., USA., pp: 1-22


  • Sotoca, A.M., M.D.S. Gelpke, S. Boeren, A. Strom and J.A. Gustafsson et al., 2010. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol. Cell. Proteom., Vol. 10.
    CrossRef    


  • Barua, S., S. Kuizon and M.A. Junaid, 2014. Folic acid supplementation in pregnancy and implications in health and disease. J. Biomed. Sci., Vol. 21.


  • Sugano, M., 2006. Soy in Health and Disease Prevention. CRC Press, Boca Raton, FL., ISBN-13: 978-0849335952, Pages: 328


  • Tavva, V.S., Y.H. Kim and I.A. Kagan, R.D. Dinkins, K.H. Kim and G.B. Collins, 2007. Increased α-tocopherol content in soybean seed overexpressing the Perilla frutescens γ-tocopherol methyltransferase gene. Plant Cell Rep., 26: 61-70.
    CrossRef    Direct Link    


  • Wiseman, H., 1999. The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens. Proc. Nutr. Soc., 58: 139-146.
    PubMed    Direct Link    


  • Wiseman, H., J.D. O'Reilly, H. Adlercreutz, A.I. Mallet, E.A. Bowey, I.R. Rowland and T.A.B. Sanders, 2000. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr., 72: 395-400.
    Direct Link    


  • Xiao, C.W., 2008. Health effects of soy protein and isoflavones in humans. J. Nutr., 138: 1244S-1249S.
    PubMed    Direct Link    


  • Sacks, F.M., A. Lichtenstein, L. van Horn, W. Harris, P. Kris-Etherton and M. Winston, 2006. Soy protein, isoflavones and cardiovascular health: An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, 113: 1034-1044.
    CrossRef    PubMed    Direct Link    


  • Singh, P., R. Kumar, S.N. Sabapathy and A.S. Bawa, 2008. Functional and edible uses of soy protein products. Compr. Rev. Food Sci. Food Saf., 7: 14-28.
    CrossRef    Direct Link    

  • © Science Alert. All Rights Reserved